Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Chattopadhyay K.

Indian J Hum Genet. 2011 Sep;17(3):132-44. doi: 10.4103/0971-6866.92087.

PMID:
22345983
[PubMed]
Free PMC Article
2.

CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.

Chatterjee K, Dandara C, Hoffman M, Williamson AL.

BMC Cancer. 2010 Jun 10;10:278. doi: 10.1186/1471-2407-10-278.

PMID:
20537184
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.

Cox JT.

Baillieres Clin Obstet Gynaecol. 1995 Mar;9(1):1-37. Review.

PMID:
7600720
[PubMed - indexed for MEDLINE]
4.

Susceptibility to cervical cancer: an overview.

de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM.

Gynecol Oncol. 2012 Aug;126(2):304-11. doi: 10.1016/j.ygyno.2012.03.047. Epub 2012 Apr 4. Review.

PMID:
22484226
[PubMed - indexed for MEDLINE]
5.

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R.

Rev Panam Salud Publica. 2004 Feb;15(2):75-89.

PMID:
15030652
[PubMed - indexed for MEDLINE]
6.

CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.

Chatterjee K, Williamson AL, Hoffman M, Dandara C.

J Med Virol. 2011 Apr;83(4):630-6. doi: 10.1002/jmv.22009.

PMID:
21328377
[PubMed - indexed for MEDLINE]
7.

HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.

Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, Sinnott P, Stern PL.

Int J Cancer. 1998 Oct 5;78(2):166-71.

PMID:
9754647
[PubMed - indexed for MEDLINE]
8.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

PMID:
17380109
[PubMed - indexed for MEDLINE]
Free Article
9.

Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis.

Nunobiki O, Ueda M, Toji E, Yamamoto M, Akashi K, Sato N, Izuma S, Torii K, Tanaka I, Okamoto Y, Noda S.

Patholog Res Int. 2011;2011:364069. doi: 10.4061/2011/364069. Epub 2011 May 31.

PMID:
21660264
[PubMed]
Free PMC Article
10.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
[PubMed - indexed for MEDLINE]
11.
12.

Impact of polymorphism in IL-1RA gene on the risk of cervical cancer.

Tamandani DM, Sobti RC, Shekari M, Kaur S, Huria A.

Arch Gynecol Obstet. 2008 Jun;277(6):527-33.

PMID:
18008080
[PubMed - indexed for MEDLINE]
13.

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.

Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL.

J Natl Cancer Inst. 2003 Sep 3;95(17):1336-43.

PMID:
12953088
[PubMed - indexed for MEDLINE]
Free Article
14.

The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies.

Moore EE, Wark JD, Hopper JL, Erbas B, Garland SM; CeCaGeEn Study Group.

Twin Res Hum Genet. 2012 Feb;15(1):79-86. doi: 10.1375/twin.15.1.79.

PMID:
22784457
[PubMed - indexed for MEDLINE]
15.

Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.

Dong DD, Yang H, Li K, Xu G, Song LH, Fan XL, Jiang XL, Yie SM.

Reprod Sci. 2010 Aug;17(8):718-23. doi: 10.1177/1933719110369183. Epub 2010 May 5.

PMID:
20445010
[PubMed - indexed for MEDLINE]
16.

Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.

Seck AC, Faye MA, Critchlow CW, Mbaye AD, Kuypers J, Woto-Gaye G, Langley C, De EB, Holmes KK, Kiviat NB.

Int J STD AIDS. 1994 May-Jun;5(3):189-93.

PMID:
8061090
[PubMed - indexed for MEDLINE]
17.

[Human papillomavirus and cervical cancer].

Matsumoto K.

Nihon Rinsho. 2007 Nov;65(11):2113-24. Review. Japanese.

PMID:
18018579
[PubMed - indexed for MEDLINE]
18.

Global burden of human papillomavirus and related diseases.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Review.

PMID:
23199955
[PubMed - indexed for MEDLINE]
19.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
[PubMed - indexed for MEDLINE]
20.

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.

Jenkins D.

Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Review.

PMID:
18653221
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk